Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MRPS26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HNRNPM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPIL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR2J2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HEPACAM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORA64 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BNIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRPM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBA1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TELO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSTZ1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CORO1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANAPC15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSNA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB49 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASCC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLN6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on